Enyi Shi

Cardiovascular Magnetic Resonance for Early Detection of Cancer Therapy-Related Cardiac Dysfunction: From Multiparametric Tissue Signatures to Clinical Pathways

Cancer therapy-related cardiac dysfunction (CTRCD) can compromise cardiovascular health and the delivery of anticancer treatment. Echocardiography and cardiac biomarkers remain the first-line surveillance tools; cardiovascular magnetic resonance (CMR) provides complementary asses...